The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study
Titel:
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study
Auteur:
Santarsieri, Anna Mitchell, Emily Pham, My H Sanghvi, Rashesh Jablonski, Janina Lee-Six, Henry Sturgess, Katherine Brice, Pauline Menne, Tobias F Osborne, Wendy Creasey, Thomas Ardeshna, Kirit M Baxter, Joanna Behan, Sarah Bhuller, Kaljit Booth, Stephen Chavda, Nikesh D Collins, Graham P Culligan, Dominic J Cwynarski, Kate Davies, Andrew Downing, Abigail Dutton, David Furtado, Michelle Gallop-Evans, Eve Hodson, Andrew Hopkins, David Hsu, Hannah Iyengar, Sunil Jones, Stephen G Karanth, Mamatha Linton, Kim M Lomas, Oliver C Martinez-Calle, Nicolas Mathur, Abhinav McKay, Pamela Nagumantry, Sateesh K Phillips, Elizabeth H Phillips, Neil Rudge, John F Shah, Nimish K Stafford, Gwyneth Sternberg, Alex Trickey, Rachel Uttenthal, Benjamin J Wetherall, Natasha Zhang, Xiao-Yin McMillan, Andrew K Coleman, Nicholas Stratton, Michael R Laurenti, Elisa Borchmann, Peter Borchmann, Sven Campbell, Peter J Rahbari, Raheleh Follows, George A
Verschenen in:
Lancet oncology
Paginering:
Jaargang 26 () nr. 1 pagina's 98-109
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license